ホーム › 転移性癌 › カリフォルニア州 › Los Angeles
Los Angeles、CAにおける転移性癌の臨床試験
Los Angelesとその周辺地域（約30マイル以内）の拠点で、転移性癌に関する57件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
被験者募集中第2相
- The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
被験者募集中第1相
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
被験者募集中第1/2相
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
被験者募集中第1相
- Cedars-Sinai Medical Center, Los Angeles
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
被験者募集中第1相
- University of California - Los Angeles, Los Angeles
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
被験者募集中第1相
- University of California Los Angeles, Los Angeles
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
被験者募集中第2/3相
- Norris Comprehensive Cancer Center, Los Angeles
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
被験者募集中第1/2相
- Children's Hospital Los Angeles, Los Angeles
- University of California at Los Angeles, Los Angeles
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
被験者募集中第2/3相
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- UCLA Department of Medicine - Hematology/Oncology, Los Angeles
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
被験者募集中第3相
- Oncura Health - Good Samaritan, Los Angeles
- California Research Institute, Los Angeles
Intratumoral N17350 in Advanced Solid Tumors
被験者募集中第1/2相
- The Angeles Clinic and Research Institute, Los Angeles
- UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
被験者募集中第1相
- USC Norris Comprehensive Cancer Center, Los Angeles
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
被験者募集中第3相
- UCLA Hematology/Oncology - Westwood (Building 100), Los Angeles
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
被験者募集中第3相
- TRIO-US (Translational Research in Oncology-US), Los Angeles
- UCLA Hematology/Oncology - Santa Monica, Los Angeles
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
被験者募集中第3相
- USC/Norris Comprehensive Cancer Center, Los Angeles
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
被験者募集中第1/2相
- California Research Institute (CRI), Los Angeles
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
被験者募集中第1/2相
- UCLA Hematology & Oncology ( Site 0003), Los Angeles
CREO - Microwave Ablation Feasibility Study
被験者募集中
- Cedars Sinai, Los Angeles
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Clinical Study Site, Los Angeles
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
被験者募集中第1相
- USC/Norris Comprehensive Cancer Center, Los Angeles
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
被験者募集中第3相
- Cedars-Sinai Medical Center, Los Angeles
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
被験者募集中第1/2相
- Avenzo Therapeutics Recruiting Site, Los Angeles
- Avenzo Therapeutics Recruiting Site, Los Angeles
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- START Los Angeles, Los Angeles
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
被験者募集中第3相
- Los Angeles Cancer Network, Los Angeles
- Cedars-Sinai Cancer at Cedars-Sinai Medical Facility, Los Angeles
- Los Angeles Cancer Network_Century City, Los Angeles
- 他3件
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
被験者募集中第1相
- The Angeles Clinic, Los Angeles
- UCLA, Los Angeles
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
被験者募集中第2相
- University of California Los Angeles, Los Angeles
- Samuel Oschin Cancer Center, Los Angeles
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
被験者募集中第1相
- University of California, Los Angeles (UCLA) - Division of Hematology-Oncology, Los Angeles
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
被験者募集中第2相
- Research Site, Los Angeles
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- University of California, Los Angeles (UCLA), Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
被験者募集中第1相
- The Angeles Clinic and Research Institute, Los Angeles
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
被験者募集中第1相
- START Los Angeles, Los Angeles
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
被験者募集中第1相
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
被験者募集中第1相
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- USC Norris Comprehensive Cancer Center, Los Angeles
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- The Angeles Clinic and Research Institute, Los Angeles
A Study of PYX-201 in Advanced Solid Tumors
被験者募集中第1相
- Ronald Reagan UCLA Medical Center, Los Angeles
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
被験者募集中第1相
- Cedars-Sinai Medical Center, Los Angeles
REMASTer: REcurrent Brain Metastases After SRS Trial
被験者募集中
- UCLA, Los Angeles
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
被験者募集中第2相
- VA Greater Los Angeles Healthcare System, Los Angeles
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
被験者募集中第1相
- The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
被験者募集中第3相
- UCLA Hematology Oncology Santa Monica, Los Angeles
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
被験者募集中第2/3相
- Helios Clinical Research, Los Angeles
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
被験者募集中第1/2相
- USC Norris Comprehensive Cancer Center, Los Angeles
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
被験者募集中第1/2相
- Cedars-Sinai Medical Center, Los Angeles
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
被験者募集中第2/3相
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
被験者募集中第3相
- University of California Los Angeles, Los Angeles
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
被験者募集中第2/3相
- The Angeles Clinic and Research Institute, Los Angeles
- University of California Los Angeles, Los Angeles
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
被験者募集中第2相
- USC/Norris Cancer Center, Los Angeles
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- USC Norris Comprehensive Cancer Center, Los Angeles
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
被験者募集中第1相
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
被験者募集中第1/2相
- Los Angeles General Medical Center, Los Angeles
- USC/Norris Comprehensive Cancer Center, Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
被験者募集中
- Cedars-Sinai Medical Center, Los Angeles
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
被験者募集中第1相
- USC - Norris Comprehensive Cancer Center, Los Angeles
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
被験者募集中第3相
- Usc Norris Comprehensive Cancer Center, Los Angeles
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
被験者募集中第1相
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
被験者募集中第1相
- University of Southern California, Los Angeles
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
被験者募集中第1/2相
- University of Southern California, Los Angeles
他の都市における転移性癌の試験
- Houston, TX104件の研究
- New York City, NY93件の研究
- Nashville, TN70件の研究
- Boston, MA63件の研究
- St. Louis, MO54件の研究
- Arlington, VA53件の研究
- Philadelphia, PA46件の研究
- Chicago, IL45件の研究
- San Antonio, TX44件の研究
- Washington, DC43件の研究
- Dallas, TX42件の研究
- Seattle, WA39件の研究
Los Angelesにおける他の研究
- 非小細胞肺癌87件の研究
- がん（全種類）74件の研究
- 乳がん73件の研究
- 前立腺がん61件の研究
- 大腸癌59件の研究
- 卵巣がん50件の研究
- 肺がん45件の研究
- 頭頸部扁平上皮癌42件の研究
- 膵臓がん35件の研究
- 子宮内膜がん34件の研究
- 悪性黒色腫34件の研究
- トリプルネガティブ乳がん27件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。